Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

INTRODUCTION: Iron deficiency anemia (IDA) is common in patients with gastrointestinal (GI) disorders and can adversely affect quality of life. Oral iron is poorly tolerated in many patients with GI disorders. Ferumoxytol is approved for the intravenous treatment of IDA in patients with chronic kidn...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Exp Gastroenterol
Asıl Yazarlar: Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946860/
https://ncbi.nlm.nih.gov/pubmed/27468245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S101473
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller